Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. May 14, 2005; 11(18): 2744-2747
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2744
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2744
Variable | Parameter estimate (SE) | Conditional risk ratio (95% CI) | P (χ2) |
Overall pBcl-2 | -1.216 (0.340) | 0.297 (0.152-0.577) | 0.001 |
(n = 59) TNM | 0.582 (0.246) | 1.790 (1.104-2.902) | 0.018 |
Age (yr) | 0.037 (0.017) | 1.038 (1.004-1.073) | 0.026 |
pBax | 0.734 (0.360) | 2.084 (1.029-4.222) | 0.041 |
Site | -0.566 (0.487) | 0.568 (0.219-1.474) | 0.245 |
Grade | 0.169 (0.268) | 1.184 (0.701-2.001) | 0.528 |
Gender | 0.061 (0.352) | 1.063 (0.534-2.118) | 0.862 |
- Citation: Dong M, Zhou JP, Zhang H, Guo KJ, Tian YL, Dong YT. Clinicopathological significance of Bcl-2 and Bax protein expression in human pancreatic cancer. World J Gastroenterol 2005; 11(18): 2744-2747
- URL: https://www.wjgnet.com/1007-9327/full/v11/i18/2744.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i18.2744